Status:
COMPLETED
A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
The purpose of this study is to describe demographic and clinical characteristics of participants who are hospitalized due to coronavirus 2019 (COVID-19), treatment use for COVID-19 and COVID-19 sympt...
Eligibility Criteria
Inclusion
- • At least one diagnosis code for COVID-19 (International Classification of Diseases (ICD)-10: U07.1 or B34.2) during hospitalization
Exclusion
- • None
Key Trial Info
Start Date :
August 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2022
Estimated Enrollment :
9282 Patients enrolled
Trial Details
Trial ID
NCT04828772
Start Date
August 17 2020
End Date
February 7 2022
Last Update
May 12 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Minato-ku, Tokyo, Japan, 108-0074
2
Medical Data Vision
Tokyo, Japan